Pirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney diseaseJuly 13, 2026 Remadevi V, Jamadar A, Varghese MM, Gunewardena S, Wallace DP, Rao R. (2026). Pirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney disease. bioRxiv. DOI: 10.1101/2025.08.25.672225 [Article] [DOI] https://www.pkd-rrc.org/wp-content/uploads/2021/04/PKDRRC_Logo_final-300x141.png 0 0 Nicole Reed https://www.pkd-rrc.org/wp-content/uploads/2021/04/PKDRRC_Logo_final-300x141.png Nicole Reed2026-07-13 13:27:082026-07-13 13:27:10Pirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney disease
